BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20042709)

  • 1. Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia.
    Toporsian M; Jerkic M; Zhou YQ; Kabir MG; Yu LX; McIntyre BA; Davis A; Wang YJ; Stewart DJ; Belik J; Husain M; Henkelman M; Letarte M
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):509-17. PubMed ID: 20042709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia.
    Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M
    Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.
    Jerkic M; Kabir MG; Davies A; Yu LX; McIntyre BA; Husain NW; Enomoto M; Sotov V; Husain M; Henkelman M; Belik J; Letarte M
    Cardiovasc Res; 2011 Dec; 92(3):375-84. PubMed ID: 21859819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia.
    Jerkic M; Sotov V; Letarte M
    Oxid Med Cell Longev; 2012; 2012():686972. PubMed ID: 23320130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin regulates cyclooxygenase-2 expression and activity.
    Jerkic M; Rivas-Elena JV; Santibanez JF; Prieto M; Rodríguez-Barbero A; Perez-Barriocanal F; Pericacho M; Arévalo M; Vary CP; Letarte M; Bernabeu C; López-Novoa JM
    Circ Res; 2006 Aug; 99(3):248-56. PubMed ID: 16840721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice.
    Belik J; Jerkic M; McIntyre BA; Pan J; Leen J; Yu LX; Henkelman RM; Toporsian M; Letarte M
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1170-8. PubMed ID: 19820034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
    Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S
    PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
    Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
    J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling.
    Santibanez JF; Letamendia A; Perez-Barriocanal F; Silvestri C; Saura M; Vary CP; Lopez-Novoa JM; Attisano L; Bernabeu C
    J Cell Physiol; 2007 Feb; 210(2):456-68. PubMed ID: 17058229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of oxidative stress to endothelial dysfunction in hereditary hemorrhagic telangiectasia.
    Jerkic M; Letarte M
    Front Genet; 2015; 6():34. PubMed ID: 25763011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced angiogenic responses in adult Endoglin heterozygous mice.
    Jerkic M; Rodríguez-Barbero A; Prieto M; Toporsian M; Pericacho M; Rivas-Elena JV; Obreo J; Wang A; Pérez-Barriocanal F; Arévalo M; Bernabéu C; Letarte M; López-Novoa JM
    Cardiovasc Res; 2006 Mar; 69(4):845-54. PubMed ID: 16405930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice.
    Düwel A; Eleno N; Jerkic M; Arevalo M; Bolaños JP; Bernabeu C; López-Novoa JM
    Tumour Biol; 2007; 28(1):1-8. PubMed ID: 17108712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
    Lebrin F; Mummery CL
    Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.
    Bauer PM; Bauer EM; Rogers NM; Yao M; Feijoo-Cuaresma M; Pilewski JM; Champion HC; Zuckerbraun BS; Calzada MJ; Isenberg JS
    Cardiovasc Res; 2012 Mar; 93(4):682-93. PubMed ID: 22215724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways.
    Park S; Dimaio TA; Liu W; Wang S; Sorenson CM; Sheibani N
    J Cell Sci; 2013 Mar; 126(Pt 6):1392-405. PubMed ID: 23418351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
    Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
    Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia.
    Satomi J; Mount RJ; Toporsian M; Paterson AD; Wallace MC; Harrison RV; Letarte M
    Stroke; 2003 Mar; 34(3):783-9. PubMed ID: 12624308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
    Sugden WW; Siekmann AF
    Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.